Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)

Taiwan · Delayed Price · Currency is TWD

30.20

+0.15 (0.50%)

Jun 18, 2026, 1:30 PM CST

-0.28% (1Y)

Market Cap	1.81B +4.7%
Revenue (ttm)	1.41B +16.1%
Net Income	179.42M +42.1%
EPS	2.97
Shares Out	59.83M
PE Ratio	10.17
Forward PE	n/a
Dividend	1.30 (4.30%)
Ex-Dividend Date	Aug 26, 2025

Volume	73,012
Open	30.10
Previous Close	30.05
Day's Range	30.05 - 30.20
52-Week Range	28.57 - 32.90
Beta	0.20
Analysts	Hold
Price Target	24.76 (-18.01%)
Earnings Date	Aug 10, 2026

About TPEX:4111

Chi Sheng Pharma & Biotech Co., Ltd manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally. Its product portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic agents; hormones and adrenal cortical steroids; autonomic nerve agents; antihistamines and antipruritics; antipyretics and analgesics; antitussives and... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1962

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 4111

Full Company Profile

Financial Performance

In 2025, TPEX:4111's revenue was 1.38 billion, an increase of 18.11% compared to the previous year's 1.17 billion. Earnings were 164.28 million, an increase of 48.49%.

Financial Statements